Medical Cannabis and Workplace Attendance: Why Fewer Workers Are Calling Off Sick
Legal medical cannabis appears to reduce health-related workplace absenteeism, particularly in physically demanding occupations where pain, injury, and chronic strain are common.
A new study covering more than 20 million workers found medical cannabis legalization was associated with a 6.9% reduction in missed work due to illness or injury.
The strongest effects were observed in industries such as manufacturing, agriculture, and construction, where untreated symptoms can directly impact attendance.
Medical cannabis may improve workforce participation not by increasing productivity directly, but by helping workers better manage underlying health conditions.
The findings challenge the assumption that broader medical cannabis access necessarily harms workplace performance.
Cannabis policy and workplace outcomes are more nuanced than simple arguments about legalization, impairment, or productivity.
Does legal medical cannabis cause workers to miss more work? According to a new study, the opposite appears to be true. Researchers found that states with medical cannabis laws experienced lower rates of health-related absenteeism, especially among workers in physically demanding jobs where pain and chronic health issues are common.
For years, opponents of medical cannabis have warned that expanded access would reduce workplace productivity and increase employee absenteeism. A new study suggests the opposite may be happening.
Researchers from the University of Southern Maine and the University of Georgia analyzed workplace absenteeism data spanning more than three decades and covering over 20 million American workers. Their findings, recently published in the Journal of Workplace Behavioral Health, indicate that legalizing medical cannabis is associated with a meaningful reduction in health-related absences from work. Specifically, medical cannabis legalization was linked to a 6.9% decrease in workers missing shifts because of illness, injury, or other health conditions (https://www.tandfonline.com/doi/full/10.1080/15555240.2026.2680016).
The result is notable because it directly challenges one of the most common assumptions surrounding cannabis policy. The study found that absenteeism declined after medical cannabis laws were enacted, with the strongest effects occurring in occupations where physical strain and chronic pain are common. These included manufacturing, agriculture, construction, and other manual labor industries. (Marijuana Moment)
"Medical cannabis is not simply a psychoactive substance. It is a therapeutic intervention for many patients managing chronic symptoms."
That distinction matters. Workers in physically demanding occupations often experience musculoskeletal pain, inflammation, repetitive stress injuries, and other chronic conditions that can make showing up to work difficult. When effective symptom management becomes available, attendance improves.
The endocannabinoid system plays a central role in regulating pain perception, inflammation, stress response, and sleep quality, all of which influence a person's ability to function day-to-day. Research published through the National Institutes of Health has demonstrated that cannabinoids interact with multiple pathways involved in pain signaling and homeostasis (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/).
"The goal of medical cannabis is not intoxication. The goal is symptom control that improves daily function."
In practical terms, a worker whose chronic pain is better controlled may be less likely to call off work. A patient sleeping through the night may be more capable of completing a physically demanding shift. Someone experiencing less anxiety or fewer inflammatory symptoms may be better able to remain engaged in the workforce.
Importantly, the study does not suggest that cannabis directly increases productivity. Rather, it suggests that improved health leads to improved attendance. That is a fundamentally different mechanism.
"Attendance is often a downstream measure of health."
This finding aligns with previous research examining medical cannabis and workforce outcomes. Earlier studies have reported reductions in workplace injuries, workers' compensation claims, and sickness-related absences following implementation of medical cannabis programs. Some analyses have also found improved labor force participation among older adults with qualifying medical conditions after medical cannabis access became available (https://www.nber.org/papers/w17101; https://www.cannamd.com/does-marijuana-legalization-affect-workplace-safety-health/). (CannaMD Marijuana Doctors & Cards)
That said, the broader relationship between cannabis and employment remains complex. Research examining heavy or problematic cannabis use has found associations with adverse workplace outcomes, including higher rates of job loss and workplace injuries in certain populations (https://pmc.ncbi.nlm.nih.gov/articles/PMC6314892/; https://pmc.ncbi.nlm.nih.gov/articles/PMC8864412/). These findings underscore an important distinction.
"Medical cannabis policy is not the same thing as unrestricted cannabis use."
The new absenteeism study specifically examined medical cannabis laws, not recreational legalization. It focused on regulated access for patients seeking symptom relief under physician supervision and state medical programs. That context matters because medical use is often driven by underlying health needs rather than purely recreational motivations. (Marijuana Moment)
The broader implication is difficult to ignore. If workers miss fewer days because their symptoms are better managed, then medical cannabis may function less like a workplace liability and more like a health intervention.
"Cannabis does not create healthier workers. It may help unhealthy workers function more effectively."
As policymakers, employers, insurers, and healthcare systems continue to evaluate the role of cannabinoid medicine, studies like this shift the conversation away from ideology and toward measurable outcomes. The question becomes less about whether cannabis is inherently good or bad and more about whether patients are healthier, more functional, and better able to participate in daily life when they have access to it.
For many workers dealing with chronic pain, inflammation, sleep disruption, or stress-related conditions, the answer increasingly appears to be yes.
According to a 2026 study analyzing more than 20 million workers, states with medical cannabis laws experienced a 6.9% reduction in health-related workplace absences. The strongest effects occurred in physically demanding industries where chronic pain and injury are common.
Not directly. The findings suggest medical cannabis may improve attendance by helping workers better manage symptoms such as pain, inflammation, sleep disturbances, and stress. Improved health can support workplace participation, but attendance and productivity are not the same measure.
Matthew Myro Rothman is Chief Science Officer and VP of Marketing at EM2P2 and CannaLnx, where he helps bridge medical cannabis, healthcare infrastructure, patient education, and emerging technology. A lifelong musician, writer, philosopher, and cannabis science expert, Matthew spent more than 15 years working in cultivation, consulting, and medical cannabis operations throughout California before returning to Ohio to help shape the future of intelligent cannabis medicine. He holds a graduate degree in Philosophy, Cosmology, and Consciousness from California Institute of Integral Studies and writes extensively on cannabis science, consciousness, wellness, and human performance.
Please note: You are not currently logged in. Only members can contribute comments. If you would like to contribute click the button below.
